Kinetics of circulating immunoglobulin M in sepsis: Relationship with final outcome

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Giamarellos Bourboulis, Evangelos J ^a   Apostolidou, Efterpi ^b   Lada, Malvina ^c   Perdios, Ioannis ^d   Gatselis, Nikolaos K ^e   Tsangaris, Iraklis ^a   Georgitsi, Marianna ^a   Bristianou, Magdalini ^f   Kanni, Theodora ^a   Sereti, Kalliopi ^c   Kyprianou, Miltiades A ^a   Kotanidou, Anastasia ^g   Armaganidis, Apostolos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Intensive Care Unit   (Greece)

^c SISMANOGLIO HOSPITAL   (Greece)

^d G GENNIMATAS GENERAL HOSPITAL   (Greece)

^e UNIVERSITY OF THESSALY   (Greece)

^f General Hospital of Lamia   (Greece)

^g UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HYPERTENSIVE FACTOR; IMMUNOGLOBULIN M;

AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; KINETICS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SURVIVOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; APACHE; BLOOD; CLINICAL TRIAL; CRITICAL ILLNESS; GREECE; MONONUCLEAR CELL; PROGNOSIS; PROSPECTIVE STUDY; SHOCK, SEPTIC; TREATMENT OUTCOME;

AGED; APACHE; CRITICAL ILLNESS; FEMALE; GREECE; HUMANS; IMMUNOGLOBULIN M; LEUKOCYTES, MONONUCLEAR; MALE; PROGNOSIS; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 84885707035     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13073     Document Type: Article

References (17)

1. Giamarellos-Bourboulis EJ, Raftogiannis M. The immune response to severe bacterial infections: consequences for therapy. Expert Rev Anti Infect Ther 2012, 10:369-380. 10.1586/eri.12.2, 22397569.
2. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011, 306:2594-2605. 10.1001/jama.2011.1829, 3361243, 22187279.
3. Racine R, Winslow GM. IgM in microbial infections: taken for granted?. Immunol Lett 2009, 125:79-85. 10.1016/j.imlet.2009.06.003, 2747358, 19539648.
4. Kreymann KG, de Heer G, Nierhaus A, Kluge S. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 2007, 35:2677-2685. 10.1097/01.CCM.0000295263.12774.97, 18074464.
5. Laupland KB, Kirkpatrick AW, Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 2007, 35:2686-2692. 10.1097/01.CCM.0000295312.13466.1C, 18074465.
6. Levy M, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500.
7. Munsell MA, Buscaglia JM. Acute pancreatitis. J Hosp Med 2010, 5:241-250. 10.1002/jhm.574, 20394032.
8. Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbath S, Tamm M, Müller B. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. A randomized trial. Am J Resp Crit Care Med 2006, 174:84-93. 10.1164/rccm.200512-1922OC, 16603606.
9. Rello J, Paiva JA, Baraibar J, Barcenilla F, Bodi M, Castander D, Correa H, Diaz E, Garnacho J, Llorio M, Rios M, Rodriguez A, Solé-Violán J. International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest 2001, 120:955-970. 10.1378/chest.120.3.955, 11555535.
10. Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB. Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med 1997, 15:148-151. 10.1016/S0735-6757(97)90087-5, 9115515.
11. Calandra T, Cohen J. The international sepsis forum consensus conference definitions of infections in the intensive care unit. Crit Care Med 2005, 33:1539-1548.
12. Gogos C, Kotsaki A, Pelekanou A, Giannikopoulos G, Vaki I, Maravitsa P, Adamis S, Alexiou Z, Andrianopoulos G, Antonopoulou A, Athanassia S, Baziaka F, Charalambous A, Christodoulou S, Dimopoulou I, Floros I, Giannitsioti E, Gkanas P, Ioakeimidou A, Kanellakopoulou K, Karabela N, Karagianni V, Katsarolis I, Kontopithari G, Kopterides P, Koutelidakis I, Koutoukas P, Kranidioti H, Lignos M, Louis K, et al. Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care 2010, 14:R96. 10.1186/cc9031, 2911733, 20504311.
13. Livaditi O, Giamarellos-Bourboulis EJ, Kakkas I, Kaspimali V, Lymberi P, Papasteriades C, Douzinas E. Grouping of patients with common variable immunodeficiency based on immunoglobulin biosynthesis: comparison with a classification system on CD4-naïve cells. Immunol Lett 2007, 114:103-109. 10.1016/j.imlet.2007.09.006, 17977604.
14. Taccone PS, Stordeur P, De Backer D, Creteur J, Vincent JL. γ-globulin levels in patients with community-acquired septic shock. Shock 2009, 32:379-385. 10.1097/SHK.0b013e3181a2c0b2, 19295479.
15. Venet F, Gebeile R, Bancel J, Guignant C, Poitevin-Later F, Malcus C, Lepape A, Monneret G. Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. Int Immunopharmacol 2011, 11:2086-2090. 10.1016/j.intimp.2011.08.024, 21924385.
16. Moitra R, Beal DR, Belikoff BG, Remick DG. Presence of pre-existing antibodies mediate survival in sepsis. Shock 2012, 37:56-62. 10.1097/SHK.0b013e3182356f3e, 3241849, 21921828.
17. Rauch PJ, Chudnoskiy A, Robbins CS, Webe GF, Etzodt M, Hilgendorf I, Tiglao E, Figueiredo JL, Iwamoto Y, Theurl I, Gorbatov R, Waring MT, Chicoine AT, Mouded M, Pittet MJ, Nahrendorf M, Wessleder R, Swirski FK. Innate response activator B cells protect against microbial sepsis. Science 2012, 335:597-601. 10.1126/science.1215173, 3279743, 22245738.